nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association between ambient air pollution and county-level cardiovascular mortality in the United States by social deprivation index
|
Bevan, Graham H |
|
|
235 |
C |
p. 125-131 |
artikel |
2 |
Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials
|
Pilgrim, Thomas |
|
|
235 |
C |
p. 140-148 |
artikel |
3 |
Bleeding avoidance strategies and percutaneous coronary intervention outcomes: A 10-year observation from a Japanese Multicenter Registry
|
Sawano, Mitsuaki |
|
|
235 |
C |
p. 113-124 |
artikel |
4 |
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics
|
Chertow, Glenn M. |
|
|
235 |
C |
p. 1-11 |
artikel |
5 |
Editorial Board
|
|
|
|
235 |
C |
p. iii |
artikel |
6 |
Edoxaban versus warfarin in patients with atrial fibrillation in relation to the risk of stroke: A secondary analysis of the ENGAGE AF-TIMI 48 study
|
de Groot, Joris R. |
|
|
235 |
C |
p. 132-139 |
artikel |
7 |
Impact of insurance status on ICD implantation practice patterns: Insights from the NCDR ICD registry
|
Ahmed, Imdad |
|
|
235 |
C |
p. 44-53 |
artikel |
8 |
Impact of targeted pulmonary arterial hypertension therapy in patients with combined post- and precapillary pulmonary hypertension
|
Moghaddam, Nima |
|
|
235 |
C |
p. 74-81 |
artikel |
9 |
Information for Readers
|
|
|
|
235 |
C |
p. iv |
artikel |
10 |
Interventional cardiologists’ perceptions of percutaneous coronary intervention quality measurement and feedback
|
Prabhu, Krishna M |
|
|
235 |
C |
p. 97-103 |
artikel |
11 |
Modified design of stimulation of the left ventricular endocardium for cardiac resynchronization therapy in nonresponders, previously untreatable and high-risk upgrade patients (SOLVE-CRT) trial
|
Singh, Jagmeet P. |
|
|
235 |
C |
p. 158-162 |
artikel |
12 |
Percutaneous coronary intervention in patients with stable coronary artery disease and left ventricular systolic dysfunction: insights from the VA CART program
|
Brophy, Todd J. |
|
|
235 |
C |
p. 149-157 |
artikel |
13 |
Periodontal Disease, Atrial Fibrillation and Stroke
|
Sen, Souvik |
|
|
235 |
C |
p. 36-43 |
artikel |
14 |
Prevalence of ideal cardiovascular health in young adults: A birth cohort from southern Brazil
|
Oliveira, Ricardo Santos |
|
|
235 |
C |
p. 65-73 |
artikel |
15 |
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study
|
Capell, Warren H. |
|
|
235 |
C |
p. 12-23 |
artikel |
16 |
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance
|
Nicholls, StephenJ |
|
|
235 |
C |
p. 104-112 |
artikel |
17 |
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE)
|
Ambrosy, Andrew P. |
|
|
235 |
C |
p. 54-64 |
artikel |
18 |
Red blood cell transfusion threshold and mortality in cardiac intensive care unit patients
|
Jentzer, Jacob C. |
|
|
235 |
C |
p. 24-35 |
artikel |
19 |
Table of Contents
|
|
|
|
235 |
C |
p. i-ii |
artikel |
20 |
Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities
|
Albert, Nancy M. |
|
|
235 |
C |
p. 82-96 |
artikel |